National medicines policies - a review of the evolution and development processes. - Wikidata - wikimedia - TriplyDB

National medicines policies - a review of the evolution and development processes.

National medicines policies - a review of the evolution and development processes.

http://www.wikidata.org/entity/Q37703355

about

Healthcare reform in the United States and China: pharmaceutical market implications Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in Vienna The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change.Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study.Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.

P2860

Q33984685-432EDBD5-1CDF-456A-B7F2-9345DF0E25C3 Q35114582-95952C35-F9D9-4701-9423-991A8E56B43C Q35198477-AA0DA692-7701-4DF7-A5DF-E61C5299CD46 Q35198496-19C3BBE9-7863-4DBC-A734-85044B379ED3 Q35879922-22E5B31B-0C3A-4BBD-8B60-DAE94C26FAE7 Q36243403-AD6B2F29-6CB3-445D-A405-D51A8ED13B07 Q38648419-448BA13C-7132-4BB2-86D7-A3349E88FF6E

P2860

National medicines policies - a review of the evolution and development processes.

http://www.wikidata.org/entity/Q37703355

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

National medicines policies - a review of the evolution and development processes.

@en

National medicines policies - a review of the evolution and development processes.

@nl

type

label

National medicines policies - a review of the evolution and development processes.

@en

National medicines policies - a review of the evolution and development processes.

@nl

prefLabel

National medicines policies - a review of the evolution and development processes.

@en

National medicines policies - a review of the evolution and development processes.

@nl

P1433

Q37703355-21324D62-7140-4A79-BA17-B7BAC7AA2619

P1476

Q37703355-715863B4-66D9-4D48-8731-38B83D1F21A3

P2093

Q37703355-08D46291-3063-4B80-B30F-8A184D780EA2

Q37703355-397D837D-8CDD-408B-9224-4BAFB17BEA8F

Q37703355-9B7B2BB1-15A7-4382-A0FC-2EBB0CE95EB9

Q37703355-BBEA38A2-40C0-443B-807A-66B7DCFE1419

Q37703355-E2C824DA-A585-45A8-B834-C213084F39E9

P2860

Q37703355-09E37A5E-DDDC-40C1-A0C1-035D14016DA9

Q37703355-22E94CFA-9171-46ED-A4AB-8967CEEB278F

Q37703355-45313B94-5D33-479B-AEF5-CD9BFE826514

Q37703355-84C5A5D2-2030-4F10-BCEA-B7BDA24DDBCE

Q37703355-99EDBF59-024B-4707-83EB-71FDD9C43D4C

Q37703355-A22C6F39-C38B-46CD-9EB9-59A39FB7FBED

Q37703355-B92673D0-B889-4A5F-A1FC-36BF705CD50C

Q37703355-BDB9AF64-44C3-4749-8FE1-8FE37058CE54

Q37703355-D7C676B3-B772-415E-BABE-6963939E655A

Q37703355-D91C047A-EAC2-4542-B426-1093EFC941FB

P2888

Q37703355-EA0EA242-8F80-4D96-A406-F5A1F61E48D3

P304

Q37703355-90ACB31F-E7A2-479F-B7D4-FBC59AED380D

P31

Q37703355-810F694D-04FF-4470-9E48-CF28ECDDDF70

P356

Q37703355-4AF52185-5763-4380-A3B1-2CAD59305DDD

P478

Q37703355-439BDA56-37AD-4DEE-8760-B08B5AC9AEE8

P577

Q37703355-4B98CB30-36C9-4C35-951C-F707050730F1

P5875

Q37703355-8A884674-FA75-48BC-B860-119CF1239968

P6179

Q37703355-AA1945A8-3284-43E5-BE33-5D740A6D5C3D

P698

Q37703355-2806D187-95ED-4048-816E-FA188F3214F8

P932

Q37703355-A4140723-7B0B-44CF-874F-25804030A683

P356

P1433

Journal of pharmaceutical policy and practice

P1476

National medicines policies - a review of the evolution and development processes.

@en

P2093

Aukje K Mantel-Teeuwisse

http://www.w3.org/2001/XMLSchema#string

Hubert Gm Leufkens

http://www.w3.org/2001/XMLSchema#string

Joëlle M Hoebert

http://www.w3.org/2001/XMLSchema#string

Liset van Dijk

http://www.w3.org/2001/XMLSchema#string

Richard O Laing

http://www.w3.org/2001/XMLSchema#string

P2860

The concept of essential medicines: lessons for rich countries.

Health sector reform: making health development sustainable.

An integrated national pharmaceutical policy for the United Kingdom?

Ten recommendations to improve use of medicines in developing countries.

Equity and health sector reforms: can low-income countries escape the medical poverty trap?

25 years of the WHO essential medicines lists: progress and challenges.

Is Australia's national medicines policy failing? The case of COX-2 inhibitors.

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.

Trends in drug misuse recorded in primary care in the UK from 1998 to 2005.

Changing patterns of morbidity and mortality in HIV disease.

P2888

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2052-3211-6-5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261883122

http://www.w3.org/2001/XMLSchema#string

P6179

1031181313

http://www.w3.org/2001/XMLSchema#string

P698

24764540

http://www.w3.org/2001/XMLSchema#string

P932

3987068

http://www.w3.org/2001/XMLSchema#string